{"entity":{"type":"insider","cik":"0001463151","url":"/insider/0001463151","json_url":"/insider/0001463151.json","name":"Levine James E.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":17,"n_filings":10,"first":"2010-08-17","last":"2024-12-18","span_basis":"filed_date"},"name_variants":[{"name":"Levine James E.","source":"filing","n_filings":10,"first_seen":"2010-08-17","last_seen":"2024-12-18"}],"transactions":[{"id":2595911,"accession":"0000950170-24-137938","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-137938","line_url":"/filing/0000950170-24-137938#line-3","is_derivative":false,"issuer_cik":"0001213037","issuer_name":"Cardiff Oncology, Inc.","issuer_ticker":"CRDF","issuer_name_source":null,"issuer_url":"/issuer/0001213037","owner_cik":"0001463151","owner_name":"Levine James E.","owner_display_name":"Levine James E.","owner_url":"/insider/0001463151","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2400.0,"shares_display":"2,400","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":12000.0,"total_display":"12,000.00","total_whole":"12,000","shares_owned_after":67716.0,"shares_owned_after_display":"67,716","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-18","filed_date":"2024-12-18","scope":"insider"},{"id":2595906,"accession":"0000950170-24-137938","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-137938","line_url":"/filing/0000950170-24-137938#line-2","is_derivative":false,"issuer_cik":"0001213037","issuer_name":"Cardiff Oncology, Inc.","issuer_ticker":"CRDF","issuer_name_source":null,"issuer_url":"/issuer/0001213037","owner_cik":"0001463151","owner_name":"Levine James E.","owner_display_name":"Levine James E.","owner_url":"/insider/0001463151","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2752.0,"shares_display":"2,752","price_per_share":5.4162,"price_display":"5.42","price_state":"stated","total_value":14905.3824,"total_display":"14,905.38","total_whole":"14,905","shares_owned_after":65316.0,"shares_owned_after_display":"65,316","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-17","filed_date":"2024-12-18","scope":"insider"},{"id":2595902,"accession":"0000950170-24-137938","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-137938","line_url":"/filing/0000950170-24-137938#line-1","is_derivative":false,"issuer_cik":"0001213037","issuer_name":"Cardiff Oncology, Inc.","issuer_ticker":"CRDF","issuer_name_source":null,"issuer_url":"/issuer/0001213037","owner_cik":"0001463151","owner_name":"Levine James E.","owner_display_name":"Levine James E.","owner_url":"/insider/0001463151","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2564.0,"shares_display":"2,564","price_per_share":3.83,"price_display":"3.83","price_state":"stated","total_value":9820.12,"total_display":"9,820.12","total_whole":"9,820","shares_owned_after":62564.0,"shares_owned_after_display":"62,564","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-16","filed_date":"2024-12-18","scope":"insider"},{"id":6377818,"accession":"0001628280-22-025099","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-025099","line_url":"/filing/0001628280-22-025099#line-1","is_derivative":false,"issuer_cik":"0001213037","issuer_name":"Cardiff Oncology, Inc.","issuer_ticker":"CRDF","issuer_name_source":null,"issuer_url":"/issuer/0001213037","owner_cik":"0001463151","owner_name":"Levine James E.","owner_display_name":"Levine James E.","owner_url":"/insider/0001463151","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":1.557,"price_display":"1.56","price_state":"stated","total_value":46710.0,"total_display":"46,710.00","total_whole":"46,710","shares_owned_after":60000.0,"shares_owned_after_display":"60,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-16","filed_date":"2022-09-19","scope":"insider"},{"id":5079328,"accession":"0001628280-21-018433","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001628280-21-018433","line_url":"/filing/0001628280-21-018433","is_derivative":false,"issuer_cik":"0001213037","issuer_name":"Cardiff Oncology, Inc.","issuer_ticker":"CRDF","issuer_name_source":null,"issuer_url":"/issuer/0001213037","owner_cik":"0001463151","owner_name":"Levine James E.","owner_display_name":"Levine James E.","owner_url":"/insider/0001463151","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":6.466666666666667,"price_display":"6.47","price_state":"stated","total_value":194000.0,"total_display":"194,000.00","total_whole":"194,000","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-10","filed_date":"2021-09-13","scope":"insider","n_lines":5},{"id":2192777,"accession":"0001209191-20-057806","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-057806","line_url":"/filing/0001209191-20-057806#line-1","is_derivative":false,"issuer_cik":"0001463151","issuer_name":"Cidara Therapeutics, Inc.","issuer_ticker":"CDTX","issuer_name_source":null,"issuer_url":"/issuer/0001463151","owner_cik":"0001463151","owner_name":"Levine James E.","owner_display_name":"Levine James E.","owner_url":"/insider/0001463151","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":2.0144,"price_display":"2.01","price_state":"stated","total_value":100720.0,"total_display":"100,720.00","total_whole":"100,720","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-10","filed_date":"2020-11-12","scope":"insider"},{"id":9271132,"accession":"0001209191-20-020744","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-020744","line_url":"/filing/0001209191-20-020744#line-1","is_derivative":false,"issuer_cik":"0001463151","issuer_name":"Cidara Therapeutics, Inc.","issuer_ticker":"CDTX","issuer_name_source":null,"issuer_url":"/issuer/0001463151","owner_cik":"0001463151","owner_name":"Levine James E.","owner_display_name":"Levine James E.","owner_url":"/insider/0001463151","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":1.908,"price_display":"1.91","price_state":"stated","total_value":57240.0,"total_display":"57,240.00","total_whole":"57,240","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-24","filed_date":"2020-03-23","scope":"insider"},{"id":7884814,"accession":"0001209191-19-050922","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-050922","line_url":"/filing/0001209191-19-050922#line-1","is_derivative":false,"issuer_cik":"0001463151","issuer_name":"Cidara Therapeutics, Inc.","issuer_ticker":"CDTX","issuer_name_source":null,"issuer_url":"/issuer/0001463151","owner_cik":"0001463151","owner_name":"Levine James E.","owner_display_name":"Levine James E.","owner_url":"/insider/0001463151","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":1.908,"price_display":"1.91","price_state":"stated","total_value":57240.0,"total_display":"57,240.00","total_whole":"57,240","shares_owned_after":205000.0,"shares_owned_after_display":"205,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-24","filed_date":"2019-09-26","scope":"insider"},{"id":3378907,"accession":"0001463151-12-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001463151-12-000002","line_url":"/filing/0001463151-12-000002#line-1","is_derivative":false,"issuer_cik":"0001049210","issuer_name":"VERENIUM CORP","issuer_ticker":"VRNM","issuer_name_source":null,"issuer_url":"/issuer/0001049210","owner_cik":"0001463151","owner_name":"Levine James E.","owner_display_name":"Levine James E.","owner_url":"/insider/0001463151","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4994.0,"shares_display":"4,994","price_per_share":3.65,"price_display":"3.65","price_state":"stated","total_value":18228.1,"total_display":"18,228.10","total_whole":"18,228","shares_owned_after":109166.0,"shares_owned_after_display":"109,166","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-15","filed_date":"2012-05-16","scope":"insider"},{"id":9184870,"accession":"0001463151-11-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001463151-11-000011","line_url":"/filing/0001463151-11-000011#line-1","is_derivative":false,"issuer_cik":"0001049210","issuer_name":"VERENIUM CORP","issuer_ticker":"VRNM","issuer_name_source":null,"issuer_url":"/issuer/0001049210","owner_cik":"0001463151","owner_name":"Levine James E.","owner_display_name":"Levine James E.","owner_url":"/insider/0001463151","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":3.18,"price_display":"3.18","price_state":"stated","total_value":79500.0,"total_display":"79,500.00","total_whole":"79,500","shares_owned_after":104172.0,"shares_owned_after_display":"104,172","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-25","filed_date":"2011-08-29","scope":"insider"},{"id":9039002,"accession":"0001463151-11-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001463151-11-000009","line_url":"/filing/0001463151-11-000009#line-1","is_derivative":false,"issuer_cik":"0001049210","issuer_name":"VERENIUM CORP","issuer_ticker":"VRNM","issuer_name_source":null,"issuer_url":"/issuer/0001049210","owner_cik":"0001463151","owner_name":"Levine James E.","owner_display_name":"Levine James E.","owner_url":"/insider/0001463151","role":"Director, Officer (EVP, Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":1.69,"price_display":"1.69","price_state":"stated","total_value":42250.0,"total_display":"42,250.00","total_whole":"42,250","shares_owned_after":79172.0,"shares_owned_after_display":"79,172","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-12","filed_date":"2011-08-16","scope":"insider"},{"id":7437848,"accession":"0001463151-10-000050","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001463151-10-000050","line_url":"/filing/0001463151-10-000050#line-2","is_derivative":false,"issuer_cik":"0001049210","issuer_name":"VERENIUM CORP","issuer_ticker":"VRNM","issuer_name_source":null,"issuer_url":"/issuer/0001049210","owner_cik":"0001463151","owner_name":"Levine James E.","owner_display_name":"Levine James E.","owner_url":"/insider/0001463151","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25150.0,"shares_display":"25,150","price_per_share":2.51,"price_display":"2.51","price_state":"stated","total_value":63126.5,"total_display":"63,126.50","total_whole":"63,127","shares_owned_after":54172.0,"shares_owned_after_display":"54,172","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-16","filed_date":"2010-08-17","scope":"insider"},{"id":7437845,"accession":"0001463151-10-000050","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001463151-10-000050","line_url":"/filing/0001463151-10-000050#line-1","is_derivative":false,"issuer_cik":"0001049210","issuer_name":"VERENIUM CORP","issuer_ticker":"VRNM","issuer_name_source":null,"issuer_url":"/issuer/0001049210","owner_cik":"0001463151","owner_name":"Levine James E.","owner_display_name":"Levine James E.","owner_url":"/insider/0001463151","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":24856.0,"shares_display":"24,856","price_per_share":2.5,"price_display":"2.50","price_state":"stated","total_value":62140.0,"total_display":"62,140.00","total_whole":"62,140","shares_owned_after":29022.0,"shares_owned_after_display":"29,022","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-13","filed_date":"2010-08-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":17,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":17,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":17},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001213037","name":"Cardiff Oncology, Inc.","url":"/issuer/0001213037","role":"Officer (Chief Financial Officer)","n_filings":3,"first_seen":"2021-09-13","last_seen":"2024-12-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001610618","name":"Cidara Therapeutics, Inc.","url":"/issuer/0001610618","role":"Officer (Chief Financial Officer)","n_filings":3,"first_seen":"2019-09-26","last_seen":"2020-11-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001049210","name":"VERENIUM CORP","url":"/issuer/0001049210","role":"Director, Officer (Chief Executive Officer)","n_filings":4,"first_seen":"2010-08-17","last_seen":"2012-05-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001463151","retrieved_at":"2026-08-22T18:48:57+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}